TBI Bioscan Newsletter - October 2009
TBI Breakfast Meeting
TBI Breakfast session season back in full swing with a focus on Canada's biotechnology industry's leaders
Kicking off National Biotech Week, The Biotechnology Initiative used its September 17th breakfast meeting as a platform for both the launch of its newest program, the TBI mentorship program, as well as introduction to CELL-A Management study a unique CEO feedback questionnaire conducted by Koenig & Consultants Inc.
TBI's Second Annual Mix and Match Event
TBI's Second Annual Mix and Match Event
To celebrate the 2009 National Biotechnology Week, TBI's second annual Mix and Match event on September 22nd provided this opportunity for GTA professionals. Held at Canada's oldest vaccine maker, sanofi pasteur, and still one of the leading vaccine producers in the world, this proved to be an important event supporting biotechnology and commercialization of innovations.
TBI News
Mentor. Partner. Learn. Grow.
TBI recently launched its mentorship program to help develop business and science professionals and build a stronger network of expertise within Ontario. The program offers individuals the opportunity to connect with other professionals with similar interests or backgrounds to promote development, addressing the need for human capital in the biotech industry.
TBI Mentorship Program Application
Apply now to be a mentor or protege: round 1 matching deadline October 22nd.
Agricultural diversity can provide many solutions to energy needs
National Biotechnology Week is a celebration of life sciences’ contributions to society, showing how new advances are affecting our every day lives. From health to the bioeconomy to the environment, biotechnology and life sciences developments have clearly addressed many of society’s needs. The Biotechnology Initiative (TBI) believes that knowledge is a key driver to technology use, and that education is key to informed decisions about policy.
TBI Member News
CELL – A Management Study™: An exploration into Canadian Excellence in Leadership in Life Sciences
CELL – A Management Study™ is a pan Canadian survey of management practices in the Life Sciences industry. The online survey is built upon an international model for excellent management practices developed by Koenig & Consultants Inc. Today your opinion and experience count! All those who are affiliated with the Canadian Life Science industry are called to take this short survey to evaluate their company’s approach to leadership, communication, strategy, and marketing.
Immunovaccine Inc. (IMV) starts trading on TSX-V
Immunovaccine Inc. is pleased to announce it will begin trading on the TSX-Venture Exchange as of October 5, 2009. Immunovaccine Inc. will trade as a Tier 1 issuer under the ticker symbol "IMV”. The company successfully closed a concurrent round of financing to support the Phase 1 clinical for DPX-0907, a therapeutic breast ovarian and prostate cancer vaccine, and intends to start the trial in Q1 2010.
Immunovaccine Inc. is continuing to develop breakthrough technologies to make vaccines better. The company continues to strengthen its vaccine pipeline through licensing and strategic partnering.
Immunovaccine will be presenting at BioContact in Quebec City, BioPartnering Europe in London, the Life Sciences and Health Care Venture Summit in New York, Bio Investor Forum in San Francisco and Bio Europe in Vienna.
Amorfix Appoints Dr. Philippe Couillard to it's Board of Directors
TORONTO, ON - Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, announced today that Philippe Couillard, MD, former Minister of Health and Social Services for Quebec, has been appointed to its Board of Directors.
Click Here for more Member News
Upcoming TBI Events
TBI October Network Breakfast Meeting - Body Heal Thyself.
Breakfast Meeting
Metro Hall, 3rd floor,
55 John Street,
Thursday October 15th, 2009
8:00 am - 10:00 am,
7:30 am Registration
Breakthrough Technologies in Regenerative Medicine
Dr. John Davies, Professor of BioMaterials, University of Toronto & Tissue
Regeneration Therapeutics Inc.
Dr. Andras Nagy, Senior Scientist, Samuel Lunenfeld Research Institute, Mt. Sinai Hospital.
TBI October 2009 Pub Night
October 22 2009
Failte Irish Pub
201 City Centre Drive
Mississauga, On
L5B 2T4
TBI's Pub Night at Failte will be a casual opportunity to meet and network with people from all across the biotech industry. TBI continues to strive to promote a strong and integrated biotech community in Ontario. Please drop by anytime after work and join us for drinks (cash bar) and build your own network. We hope to see you all there.
Industry Events
11th Symposium of the International Diabetes Epidemiology Group (IDEG)
Quebec City
This official satellite symposium of the 20th World Congress of the International Diabetes Federation (Montreal, October 18 to 22, 2009) will be held in Quebec City from October 15 to 18, 2009 and promises to be an eye-opening experience.
Getting Your Exports On The Autobahn
October 20th, 2009
Breakfast seminar Toronto, ON.
Germany is known for being the Exportweltmeister. With a population of over 80 million, Germany is a very attractive market for Canadian exporters and is also commonly used by exporters as a gateway to central Europe.
BIO Investor Forum
October 28 2009
Early Bird Deadline Sept. 29th!
Oct. 28-30, 2009 - San Francisco, CA
BIOTECanada is pleased to offer substantial savings to their members on partnered events.
Leaders in science policy to gather in Toronto in October to discuss future directions
October 28 2009
TORONTO, Sep. 17 /CNW/ - The 2009 Canadian Science Policy Conference (CSPC), to be held Oct 28-30 in Toronto, will serve as a forum for members of the Canadian scientific community from the academic, industry, government and non-profit sectors to engage in a vigorous discussion of the most important science policy issues facing the country, and to forge lasting linkages between stakeholders and policymakers. The early-bird registration deadline for the conference has been extended to Sep 30, 2009.
Gairdner Industry Breakfast
October 29 2009
As part of the 50th Anniversary celebrations the Gairdner Foundation, in partnership with the Government of Ontario, is hosting an industry breakfast. This event will be of interest to those in biotech and pharma industries, government, venture capitalists, researchers, graduate students and postdocs.
For 2009 Toronto Program details click here
BIO-Europe 2009
November 02 2009
Early Bird Deadline August 31st!
BIO-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a "must attend" event for the biotech industry. BIOTECanada is pleased to offer substantial savings to their members on partnered events.
Click here to view more events
Feature Career Opportunities
Preclinical CRO Business Development Director
Toronto-based
Staff Writer
Aurora, ON
Senior Formulation Scientist
Markham
Click Here for a full list of employment opportunities available through TBI's careers page
Join the #1 Life Sciences Network in Ontario
The Biotechnology Initiative represents and promotes life sciences technologies and encourages their commercial success in Ontario through networking events, government advocacy, stakeholder engagement, mentoring and education and promotion of Ontario’s world-class science and industry.
Click here for more member benefits and to join the #1 Life Sciences Network in Ontario
CONTACT US
To include your announcement on TBI’s web site or upcoming Bioscan newsletter, send your release to news@ontbi.org
Please forward all releases as word documents.
